Duravest, Inc. v. VISCARDI, AG

581 F. Supp. 2d 628, 2008 U.S. Dist. LEXIS 78584, 2008 WL 4500699
District Court, S.D. New York·Decided October 7, 2008·No. 07 Civ. 10590(JSR)·Published·Cited by 9 cases

Opinion

OPINION AND ORDER

JED S. RAKOFF, District Judge.

Plaintiff Duravest, Inc. has sued a number of individuals and entities for damages associated with Duravest’s 2005 purchase of Bio-Magnetic Therapy Systems, Inc. (“BMTS”), alleging, among other things, that these individuals and entities knew BMTS was nearly worthless but engaged in fraud and misconduct to lure Duravest into purchasing it. Duravest has named the following defendants: Richard Markoll (“Markoll”), who was the Chief Executive Officer of BMTS at the time of purchase; Ernestine Binder Markoll (“Ernestine”), his wife and a shareholder in BMTS; and Biomedical Consultant SL (“BCSL”), the Markolls’ consulting company (collectively, the “Markoll defendants”); Viscardi, AG (“Viscardi”), the German brokerage involved in the sale; Wollmuth Maher & Deutsch, LLP and Mason H. Drake, Esq. (together, the “lawyer defendants”), who provided legal services to plaintiff in connection with the sale; and Bruce O’Donnell, CPA, and Bruce O’Donnell CPA/PFS, P.A. (together, the “O’Donnell defendants”), who provided accounting services to BMTS. Duravest has asserted the following federal and New York law claims against various combinations of the defendants: (1) common law fraud; (2) violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. § 1961 et seq.; (3) conversion; (4) breach of contract; (5) professional malpractice; (6) securities fraud under 15 U.S.C. § 78j; (7) securities fraud under 15 U.S.C. § 771; and (8) common law negligence.

By Memorandum Order dated April 11, 2008 (“April 11 Order”), the Court granted in part the motion to dismiss of the O’Donnell defendants, dismissing with prejudice the RICO count, which was the sole federal claim against the O’Donnell defendants, and the breach of contract count. The Court denied the motion with respect to the common law fraud and negligence claims against these defendants, but deferred ruling on whether to exercise supplemental jurisdiction over these claims until the Court had determined whether any federal claims would proceed against the other defendants. 1

Viscardi subsequently moved to dismiss the claims against it (common law fraud, securities fraud under § 771 and § 78j, and negligence) for want of personal jurisdiction under Rule 12(b)(2), Fed.R.Civ.P., or, in the alternative, for failure to state a claim under Rule 12(b)(6). At the same time, the lawyer defendants moved to dismiss the professional malpractice claim, the only claim against them, on the ground that the Court lacked supplemental jurisdiction to consider it.

Duravest’s and Viscardi’s submissions on the question of personal jurisdiction revealed a disputed issue of fact with possible relevance to the outcome of the motion. Specifically, the parties introduced conflicting evidence as to whether Fried-rich Wilhelm Gobel, the Chief Executive Officer (“CEO”) of Viscardi, had a business relationship with a New York management consulting company called The Schubert Group (“TSG”), and if so, whether that relationship involved Viscardi. At oral argument on the motion, the Court ex *632 pressed doubts that Duravest could make an evidentiary showing of contacts sufficient to establish personal jurisdiction, but nonetheless agreed to hold a hearing at which plaintiffs counsel could question Walter Schubert, the principal of TSG. The Court deferred, for the time being, any ruling on the lawyer defendants’ motion.

The Court held the personal jurisdiction evidentiary hearing on July 1, 2008. Schubert’s testimony, however, brought to light a number of troubling misrepresentations with possible relevance to Viscardi’s presence (or lack thereof) in New York. Accordingly, the Court adjourned the hearing so that Gobel, who resided in Germany, could testify as well. 2 The Court conducted the second part of the hearing on September 22, 2008.

Meanwhile, the Markoll defendants, whom plaintiff had been able to serve only much later than the other defendants, appeared and moved to dismiss, also on the ground of lack of personal jurisdiction and, in the alternative, for failure to state a claim. On September 22, in addition to the continued evidentiary hearing, the Court held oral argument on that motion.

Based on the evidence adduced at the two evidentiary hearings and on the submissions of the parties with respect to both the Markoll defendants’ and Viscardi’s motions, the Court, for the reasons to be discussed, grants those motions and dismisses both the Markoll defendants and Viscardi for lack of personal jurisdiction and, concomitantly, declines to exercise supplemental jurisdiction against the other remaining (exclusively state law) claims against the other remaining defendants.

Although the Court provided a brief overview of the events underlying this case in its April 11 Order, a further summary of the facts as they pertain to the Markoll defendants and Viscardi is warranted here. Richard Markoll founded BMTS, a closely held Virginia company, 3 in 1991, to develop and sell biomedical products that used a technique called “Pulsed Signal Technology” (“PST”). Complaint (“Compl.”) ¶¶ 52, 74; Declaration of Richard Markoll (“RM Deck”) ¶ 22. At the time of the events underlying this action, BMTS had its principal place of business in Germany, where both Markolls have resided for many years. RM Decl. ¶ 3-8, 24. Richard Mar-koll was the CEO and majority shareholder of BMTS, and Ernestine Markoll was a shareholder and employee who participated in the company’s management. Compl. ¶¶ 59-60.

Viscardi, an independent investment bank incorporated under the laws of Germany and having an office in Munich, is in the business of providing small and medium-capitalized European companies with advisory services for financing transactions and mergers and acquisitions. Compl. ¶ 12-16; Affidavit of Barbara Thatig, General Counsel and Chief Operating Officer of Viscardi (“Thatig Aff.”) ¶¶ 4-5. On February 1, 2005, in Munich, Richard Mar-koll engaged Viscardi to seek the sale of BMTS. Agreement, Ex. A to Thatig Aff. Viscardi’s CEO, Friedrich Wilhelm Gobel, unsuccessfully approached a number of companies, none of which was in New York, about purchasing BMTS, but even *633 tually placed the company with Duravest, a Florida company based in Illinois. Thá-tig Aff. ¶¶ 8,11-12.

Free access — add to your briefcase to read the full text and ask questions with AI

Duravest, Inc. v. VISCARDI, AG, 581 F. Supp. 2d 628, 2008 U.S. Dist. LEXIS 78584, 2008 WL 4500699 (S.D.N.Y. 2008).

581 F. Supp. 2d 628 (Duravest, Inc. v. VISCARDI, AG) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Untitled Case
S.D. New York, 2026
Shi v. Le
E.D. New York, 2022
Thorsen v. Sons of Norway
996 F. Supp. 2d 143 (E.D. New York, 2014)
China National Chartering Corp. v. Pactrans Air & Sea, Inc.
882 F. Supp. 2d 579 (S.D. New York, 2012)
Cacchillo v. Insmed Inc.
833 F. Supp. 2d 218 (N.D. New York, 2011)
In Re Banco Santander Securities-Optimal Litigation
732 F. Supp. 2d 1305 (S.D. Florida, 2010)